CRSP
#1274
CRISPR Therapeutics AG - Common Shares
56.7 0 USD
0.00%
Market Price
Secteur: Soins de Santé
Base: USD
Devise de Profit: USD
Range quotidien
Range Annuel
Changement quotidien
-0.49%
Changement Mensuel
+18.03%
Evolution sur 6 mois
-2.31%
Changement Annuel
+11.18%
Clôture Précédente
56.9 8
Open
56.9 8
Low
56.7 0
High
57.0 8
Volume
167
Financials
- Market Capitalization 5.48 B
- Employee 393
- Founded 2013
- CEO Samarth Kulkarni
- Website www.crisprtx.com
- Headquarter Switzerland
- FIGI UNKNOWN
- Industry Biotechnologies
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
ratio cours/bénéfice
-11.58
ratio cours/chiffre d'affaires
389.54
Related tickers
| # | Nom | Prix | 24h % | 7 jours % | 1M % | 1 an % | Cap Boursière | 7 Derniers Jours | |
|---|---|---|---|---|---|---|---|---|---|
| 1235 |  XENE Xenon Pharmaceuticals Inc. - Common Shares | 59.93 USD | -0.48% | -1.38% | -5.19% | +46.92% | 5.80 B USD | ||
| 1255 |  LGND Ligand Pharmaceuticals Incorporated - Common Stock | 284.99 USD | +0.31% | +0.93% | -0.75% | +52.30% | 5.68 B USD | ||
| 1303 |  DFTX Definium Therapeutics, Inc. - Common Shares | 38.20 USD | -3.83% | -15.17% | -10.89% | +152.81% | 5.13 B USD | ||
| 1341 |  ACAD ACADIA Pharmaceuticals Inc. - Common Stock | 28.84 USD | -0.24% | -6.00% | +11.05% | +11.31% | 4.97 B USD |